Dr David Lopez

David Lopez holds a PhD in Microbiology from the Universidad Autónoma de Madrid, where he also earned degrees in Biochemistry and Microbiology. Before joining Stablepharma, David spent five years as a Research Scientist at the National Centre for Biotechnology (CNB-CSIC), studying bacterial cell wall physiology and antibiotic resistance.

With a strong background in biochemistry, molecular biology, and microbiology, and an MBA focused on the pharmaceutical industry, David brings both scientific expertise and strategic insight to Stablepharma’s R&D team in Madrid, supporting the development of innovative thermostable vaccine and pharmaceutical products.